title: The Patients' Adherence and Adverse Drug Reactions (ADRs) which are Caused by Helicobacter pylori Eradication Regimens.
abstract: BACKGROUND
  Helicobacter pylori is a major cause of upper gastrointestinal disorders. The eradication of H. pylori has been recommended for the treatment of different gastrointestinal diseases. Notwithstanding, a combination therapy is needed for Helicobacter pylori eradication, but using these medications can be the cause, the incidence risk of patients' adherence to treatment regimens reduction and probably increase risk of Adverse Drug Reactions (ADRS), so, it is seem that evaluation the out come of combination therapy is need more than the past.
  
  
  OBJECTIVE
  The aim of present study was to determine the patients' adherence to the treatment and the ADRs with five eradiation regimens.
  
  
  METHODS
  A cross sectional study was done in a well known referral clinic of gastrointestinal disorders in Tehran, Iran.
  
  
  METHODS
  Ninety patients were evaluated the study (18 in each of the five regimens). The adherence to the treatment and the ADRs of the patients were asked during the treatment, twice, by doing telephone assays.
  
  
  METHODS
  The data were analyzed by using the SPSS, 17 software and the statistical significance was accepted for the P values of 0.05.
  
  
  RESULTS
  81% of the patients had a good adherence and there was no significant difference between the types of regimens (triple or quadruple therapy) and the adherence to the treatment regimens by the patients (p=0.6). Also, we found that there was no significant relationship between the types of regimens and the sex (p=0.99), education level (p=0.99), accommodation (p=0.93), an existence of underlying disease (p=0.86) and the concurrent use other medications (p=0.93). But there was a significant relationship between the patients' age and adherence to the treatment regimens (p=0.008). The most reported ADRs belonged to gastrointestinal (GI) disorders (an abnormal taste had the most prevalence (36.6%) among the GI disorders). There was no significant relationship between the regimen type and the GI ADRs, (p=0.48).
  
  
  CONCLUSIONS
  The findings of this study showed that the patients' adherence to the treatment regimens and the ADRs did not have a significant relationship with the various eradication regimens for H. pylori. It seems that the type of H. pylori eradication regimen may not be an important factor in the patients' adherence to the treatment regimens and the ADRs.
authors: Department of Clinical Pharmacy, Shahid Beheshti University of Medical Sciences , Tehran, Iran .
authors: Mohammad
authors: M
authors: Abbasinazari
authors: Zahra
authors: Z
authors: Sahraee
authors: Maryam
authors: M
authors: Mirahmadi
keywords: Adherence; Adverse drug reactions; Helicobacter pylori; Patients
references: Curr Opin Pharmacol. 2008 Oct;8(5):593-7
references: 18555746
references: Clin Ther. 2001 Aug;23(8):1296-310
references: 11558866
references: Control Clin Trials. 1998 Jun;19(3):257-68
references: 9620809
references: Clin Ther. 1994 Jan-Feb;16(1):110-7
references: 8205597
references: Arch Intern Med. 1993 Aug 23;153(16):1863-8
references: 8250647
references: Gut. 2007 Jun;56(6):772-81
references: 17170018
references: N Engl J Med. 2002 Oct 10;347(15):1175-86
references: 12374879
references: Aliment Pharmacol Ther. 2004 Nov 15;20(10):1071-82
references: 15569109
references: Arch Intern Med. 1999 Oct 25;159(19):2312-6
references: 10547171
references: Helicobacter. 2008 Dec;13(6):572-6
references: 19166424
references: Am J Gastroenterol. 1998 Dec;93(12):2330-8
references: 9860388
references: Am J Public Health. 1996 Feb;86(2):200-5
references: 8633736
references: Fundam Clin Pharmacol. 2009 Feb;23(1):43-52
references: 19207543
references: Aliment Pharmacol Ther. 2002 Feb;16(2):167-80
references: 11860399
references: Pharm Pract (Granada). 2006 Apr;4(2):88-94
references: 25247005
references: N Engl J Med. 2005 Aug 4;353(5):487-97
references: 16079372